Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus

INTRODUCTION: Acute bacterial skin and skin structure infections (ABSSSIs) remain among the most common infectious processes seen in the clinical setting. For patients with complicated ABSSSIs deemed to require intravenous antibiotics, vancomycin remains the mainstay therapy. Ceftaroline has been sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Claeys, Kimberly C., Zasowski, Evan J., Trinh, Trang D., Casapao, Anthony M., Pogue, Jason M., Bhatia, Nitin, Mynatt, Ryan P., Wilson, Suprat S., Arthur, Crystal, Welch, Robert, Sherwin, Robert, Hafeez, Wasif, Levine, Donald P., Kaye, Keith S., Delgado, George, Giuliano, Christopher A., Takla, Robert, Rieck, Colleen, Johnson, Leonard B., Murray, Kyle P., Gordon, James, Reyes, Kate, Hartman, Pamela, Davis, Susan L., Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522568/
https://www.ncbi.nlm.nih.gov/pubmed/30915685
http://dx.doi.org/10.1007/s40121-019-0242-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522568/
https://www.ncbi.nlm.nih.gov/pubmed/30915685
http://dx.doi.org/10.1007/s40121-019-0242-5

Ejemplares similares